| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Dec 15, 2023 | Cytosorbents Corp | CEO | Buy | 90.0 | +75,188 | 7.57% | ✗ | $100K |
| Dec 8, 2022 | Dec 9, 2022 | Cytosorbents Corp | CEO | Buy | 67.5 | +5,859 | 0.66% | ✗ | $7.4K |
| Dec 6, 2022 | Dec 8, 2022 | Cytosorbents Corp | CEO | Buy | 83.8 | +24,141 | 2.78% | ✗ | $30.5K |
| Sep 8, 2022 | Sep 12, 2022 | Cytosorbents Corp | CEO | Buy | 87.5 | +35,000 | 4.21% | ✗ | $59.5K |
| Jun 16, 2022 | Jun 21, 2022 | Cytosorbents Corp | CEO | Buy | 60.0 | +2,221 | 0.29% | ✓ | $4.1K |
| Jun 9, 2022 | Jun 10, 2022 | Cytosorbents Corp | CEO | Buy | 78.8 | +16,000 | 2.13% | ✗ | $34.8K |
| Dec 29, 2021 | Jan 3, 2022 | Cytosorbents Corp | CEO | Buy | 82.5 | +15,000 | 1.99% | ✓ | $60.7K |
| Dec 10, 2021 | Dec 13, 2021 | Cytosorbents Corp | CEO | Buy | 68.8 | +5,000 | 0.67% | ✗ | $26.3K |
| Dec 6, 2019 | Dec 6, 2019 | Cytosorbents Corp | CEO | Buy | 87.5 | +16,500 | 2.57% | ✗ | $59.4K |
| Dec 7, 2018 | Dec 11, 2018 | Cytosorbents Corp | CEO | Sell | 22.5 | -24,337 | -4.61% | ✗ | $228K |
| Sep 5, 2018 | Sep 7, 2018 | Cytosorbents Corp | CEO | Sell | 22.5 | -11,418 | -2.54% | ✗ | $167.2K |
| Jun 8, 2017 | Jun 8, 2017 | Cytosorbents Corp | CEO | Buy | 68.8 | +3,700 | 0.93% | ✗ | $14.8K |
| Jun 5, 2017 | Jun 6, 2017 | Cytosorbents Corp | CEO | Buy | 78.8 | +6,300 | 1.62% | ✗ | $25.2K |
| Dec 9, 2016 | Dec 13, 2016 | Cytosorbents Corp | CEO | Buy | 78.8 | +4,600 | 1.04% | ✗ | $24.8K |
| Aug 24, 2016 | Aug 26, 2016 | Cytosorbents Corp | CEO | Buy | 83.8 | +5,000 | 4.29% | ✗ | $24.5K |
| Sep 4, 2012 | Sep 5, 2012 | Cytosorbents Corp | CEO | Buy | 91.3 | +190,000 | 100.00% | ✗ | $24.7K |